Clene Inc. secures additional NIH grant funds for ALS therapy

Go back to Clene Inc. secures additional NIH grant funds for ALS therapy
(NASDAQ: CLNN) Delayed: 5.77 --0 (-0%)
Previous Close $5.77    52 Week High
Open $5.77    52 Week Low
Day High $5.77    P/E N/A 
Day Low $5.77    EPS
Volume 282